|
ETF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9508999999095E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27509999994879E-06 |
| Normal-vs-Stage2 |
1.282850E-03 |
| Normal-vs-Stage3 |
2.062200E-03 |
| Normal-vs-Stage4 |
9.843800E-02 |
| Stage1-vs-Stage2 |
7.823000E-01 |
| Stage1-vs-Stage3 |
3.543000E-01 |
| Stage1-vs-Stage4 |
2.013600E-01 |
| Stage2-vs-Stage3 |
6.304600E-01 |
| Stage2-vs-Stage4 |
3.119800E-01 |
| Stage3-vs-Stage4 |
4.935800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.76729999973513E-07 |
| Normal-vs-AfricanAmerican |
5.60539999999721E-05 |
| Normal-vs-Asian |
1.556220E-01 |
| Caucasian-vs-AfricanAmerican |
5.386200E-01 |
| Caucasian-vs-Asian |
4.603800E-01 |
| AfricanAmerican-vs-Asian |
5.973200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.03350000066638E-08 |
| Normal-vs-Female |
1.142940E-03 |
| Male-vs-Female |
7.737900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.98162999999196E-05 |
| Normal-vs-Extreme_Weight |
1.60889999989422E-07 |
| Normal-vs-Obese |
4.033500E-04 |
| Normal-vs-Extreme_Obese |
6.763900E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.607000E-01 |
| Normal_Weight-vs-Obese |
3.946200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.506200E-01 |
| Extreme_Weight-vs-Obese |
1.417810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.928200E-01 |
| Obese-vs-Extreme_Obese |
2.441400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.071600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.66639999998885E-06 |
| Normal-vs-Age(61-80Yrs) |
8.86170000047315E-07 |
| Normal-vs-Age(81-100Yrs) |
7.044700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.252800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.708370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.839570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.283400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.391200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.393400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.03780000149101E-08 |
| Normal-VS-Type2 PRCC |
1.219690E-03 |
| Normal-VS-KIRP CIMP |
2.210000E-01 |
| Normal-VS-Unclassified PRCC |
1.976020E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.621840E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.396400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.672600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.785400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.962200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.401580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.17860000332138E-08 |
| Normal-vs-N1 |
3.632000E-02 |
| Normal-vs-N2 |
9.268200E-02 |
| N0-vs-N1 |
5.023300E-03 |
| N0-vs-N2 |
5.679800E-01 |
| N1-vs-N2 |
4.808200E-01 |
|
|
